1. Home
  2. VCEL vs MQ Comparison

VCEL vs MQ Comparison

Compare VCEL & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$35.76

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Marqeta Inc.

MQ

Marqeta Inc.

HOLD

Current Price

$4.31

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
MQ
Founded
1989
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VCEL
MQ
Price
$35.76
$4.31
Analyst Decision
Strong Buy
Hold
Analyst Count
5
10
Target Price
$57.75
$5.36
AVG Volume (30 Days)
557.8K
2.6M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
0.32
N/A
Revenue
$276,259,000.00
$624,884,000.00
Revenue This Year
$19.40
$16.89
Revenue Next Year
$18.24
$16.36
P/E Ratio
$106.89
N/A
Revenue Growth
16.45
23.25
52 Week Low
$28.95
$3.70
52 Week High
$45.97
$7.04

Technical Indicators

Market Signals
Indicator
VCEL
MQ
Relative Strength Index (RSI) 57.65 56.61
Support Level $34.26 $3.84
Resistance Level $38.48 $4.46
Average True Range (ATR) 1.31 0.14
MACD 0.18 0.03
Stochastic Oscillator 94.02 69.23

Price Performance

Historical Comparison
VCEL
MQ

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

Share on Social Networks: